biblio
, “Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis”, Plos One, vol. 14, no. 8, p. e0220628, 2019.
, “Ultrasound assisted synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) benzamide as challenging anti-tubercular scaffold”, Molecules, vol. 23, no. 8, p. Article No: 1945, 2018.
, “Two chitotriose-specific lectins show anti-angiogenesis, induces caspase-9-mediated apoptosis and early arrest of pancreatic tumor cell cycle”, Plos One, vol. 11, no. 1, p. Article Number: e0146110, 2016.
, “Two antibacterial spiro compounds from the roots of Artemisia pallens wall: evidence from molecular docking”, Natural Product Research, vol. 36, no. 10, pp. 2465-2472, 2022.
, “Triazole-diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking”, MedChemComm, vol. 9, no. 7, pp. 1114-1130, 2018.
, “Total synthesis, structure elucidation and expanded bioactivity of icosalide A: effect of lipophilicity and ester to amide substitution on its bioactivity”, Organic & Biomolecular Chemistry, vol. 21, no. 28, pp. 5725-5731, 2023.
, “Thiazolyl-pyrazole derivatives as potential antimycobacterial agents”, Bioorganic & Medicinal Chemistry Letters, vol. 29, no. 10, pp. 1199-1202, 2019.
, “Tetrazoloquinoline-1,2,3-triazole derivatives as antimicrobial agents: synthesis, biological evaluation and molecular docking study”, Polycyclic Aromatic Compounds, vol. 42, no. 4, pp. 1920-1941, 2022.
, “Targeting dormant tuberculosis bacilli: results for molecules with a novel pyrimidone scaffold”, Chemical Biology & Drug Design, vol. 85, no. 2, pp. 201-207, 2015.
, “Synthesis of novel triazole-incorporated isatin derivatives as antifungal, antitubercular, and antioxidant agents and molecular docking study”, Journal of Heterocyclic Chemistry, vol. 54, no. 413, 2017.
, “Synthesis of new thiazole and pyrazole clubbed 1,2,3-triazol derivatives as potential antimycobacterial and antibacterial agents”, Polycyclic Aromatic Compounds, vol. 42, no. 6, pp. 3216-3237, 2022.
, “Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents”, Bioorganic Chemistry, vol. 115, p. 105192, 2021.
, “Synthesis of new 1,3,4-oxadiazole and benzothiazolylthioether derivatives of 4-arylmethylidene-3-substituted-isoxazol-5(4H)-one as potential antimycobacterial agents”, Medicinal Chemistry Research, vol. 28, no. 11, pp. 1873-1884, 2019.
, “Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1776-1783, 2016.
, “Synthesis, biological evaluation, and molecular docking study of pyridine clubbed 1,3,4-oxadiazoles as potential antituberculars”, Synthetic Communications, vol. 48, no. 5, pp. 524-540, 2018.
, “Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis”, Chemical Biology & Drug Design, vol. 90, no. 6, pp. 1206-1214, 2017.
, “Synthesis, biological evaluation and molecular docking studies of N-acylheteroaryl hydrazone derivatives as antioxidant and anti-inflammatory agents”, Research on Chemical Intermediates, vol. 42, no. 3, pp. 2707-2729, 2016.
, “Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents”, Medicinal Chemistry Research, vol. 25, no. 4, pp. 790-804, 2016.
, “Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives”, Medicinal Chemistry Research, 2017.
, “Synthesis and tyrosinase inhibition activity of trans-stilbene derivatives”, Bioorganic Chemistry, vol. 64, pp. 97-102, 2016.
, “Synthesis and evaluation of thieno[2,3-d]pyrimidin-4(3H)-ones as potential antitubercular agents (vol 6, pg 2209, 2015)”, Medchemcomm, vol. 7, no. 2, p. 379, 2016.
, “Synthesis and evaluation of thieno[2,3-d]pyrimidin-4(3H)-ones as potential antitubercular agents”, MedChemComm, vol. 6, no. 12, pp. 2209-2215, 2015.
, “Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2224-2228, 2016.
, “Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocyclyl-2,6-dicyanoanilines (vol 27, pg 979, 2017)”, Bioorganic & Medicinal Chemistry Letters, vol. 32, p. 127737, 2021.
, “Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocycl- yl-2,6-dicyanoanilines”, Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 4, pp. 979-988, 2017.
, “Synthesis and biological evaluation of some new tricyclic pyrrolo[3,2-e]tetrazolo[1,5-c]pyrimidine derivatives as potential antitubercular agents”, Archiv Der Pharmazie, vol. 351, no. 8, p. e1800040, 2018.
, “Synthesis and biological evaluation of some bicyclic [2-(2,4-dimethylphenylthio)phenyl] aniline and its amide derivatives as potential antitubercular agents”, Journal of Chemical Sciences, vol. 130, no. 3, p. 22, 2018.
, “Synthesis and biological evaluation of novel triazole-biscoumarin conjugates as potential antitubercular and anti-oxidant agents”, Research on Chemical Intermediates, vol. 44, no. 10, pp. 1-28, 2018.
, “Synthesis and biological evaluation of new fluconazole β-lactam conjugates linked via 1,2,3-triazole”, New Journal of Chemistry, vol. 41, no. 2, pp. 470-479, 2017.
, “Synthesis and biological evaluation of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)phenyl)-2-phenylthiazole derivatives”, Journal of Heterocyclic Chemistry, 2019.
, “Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives”, Research on Chemical Intermediates, vol. 44, no. 2, pp. 1247-1260, 2018.
, “Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis”, European Journal of Medicinal Chemistry, vol. 178, pp. 315-328, 2019.
, “Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as anti-mycobacterial agents”, Chemical Biology & Drug Design, vol. 90, no. 2, pp. 200-209, 2017.
, “Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 2, pp. 561-569, 2016.
, “Synthesis and antitubercular activity of new thiazolidinones with pyrazinyl and thiazolyl scaffolds”, Journal of Heterocyclic Chemistry, vol. 54, no. 1, pp. 125-130, 2017.
, “Synthesis and antitubercular activity of new benzo[b]thiophenes”, ACS Medicinal Chemistry Letters, vol. 7, no. 8, pp. 751-756, 2016.
, “Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 15, pp. 3646-3651, 2016.
, “Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives”, European Journal of Medicinal Chemistry, vol. 132, pp. 333-340, 2017.
, “Synthesis and antimycobacterial screening of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-3-yl)quinoline derivatives”, Journal of Heterocyclic Chemistry, vol. 57, no. 11, pp. 3918-3929, 2020.
, “Synthesis and antimycobacterial screening of a novel series of alpha-amino acids containing thiazole linker”, ARKIVOC, 2022.
, “Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives”, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.
, “Superoxide generation and its involvement in the growth of mycobacterium smegmatis”, Frontiers in Microbiology, vol. 8, p. Article Number: 105, 2017.
, “Sophorolipid assisted tunable and rapid gelation of silk fibroin to form porous biomedical scaffolds”, RSC Advances, vol. 5, no. 43, pp. 33955-33962, 2015.
, “Simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli”, Journal of Microbiological Methods, vol. 73, no. 1, pp. 62-68, 2008.
, “Shape and size engineered cellulosic nanomaterials as broad spectrum anti-microbial compounds”, International Journal of Biological Macromolecules, vol. 87, pp. 460-465, 2016.
, “Rottlerin derivatives and other compounds from mallotus philippinensis fruits and their potential antimycobactrial activity”, Planta Medica Letters, vol. 2, no. 1, pp. e28-e30, 2015.
, “Recursive partitioning analysis and anti-tubercular screening of 3-aminopyrazine-2-carbohydrazide derivatives”, Letters in Drug Design & Discovery, vol. 16, no. 11, pp. 1264-1275, 2019.
, “Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agents”, Future Medicinal Chemistry, vol. 7, no. 8, pp. 979-988, 2015.
, “ Rational design of coumarin derivatives as antituberculosis agents”, Future Medicinal Chemistry, vol. 10, no. 20, pp. 2431-2444, 2018.
, “Quinolidene-rhodanine conjugates: facile synthesis and biological evaluation”, European Journal of Medicinal Chemistry, vol. 125, pp. 385–399, 2017.
, “Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: synthesis and molecular docking study”, Bioorganic & medicinal chemistry letters, vol. 27, no. 4, pp. 922-928, 2017.
, “Qualitative and quantitative proteomic analysis of vitamin C induced changes in mycobacterium smegmatis”, Frontiers in Microbiology, vol. 6, p. Article Number: 451, 2015.
, “Production, purification, and characterization of taxol and 10-DABIII from a new endophytic fungus gliocladium sp isolated from the Indian yew tree, taxus baccata”, Journal of Microbiology and Biotechnology, vol. 19, no. 11, pp. 1342-1347, 2009.
, “Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay”, Medicine in Drug Discovery, vol. 13, p. 100115, 2022.
, “Presence of a functional nitrate assimilation pathway in mycobacterium smegmatis”, Microbial Pathogenesis, vol. 44, no. 1, pp. 71-77, 2008.
, “Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of mycobacterium tuberculosis in a THP1 infection model”, Journal of Biomolecular Screening, vol. 17, no. 7, pp. 966-973, 2012.
, “Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents”, International Journal of Nanomedicine, vol. 11, p. 1889—1897, 2016.
, “Phyllocladane diterpenes from anisomeles heyneana”, Journal of Asian Natural Products Research, vol. 14, no. 12, pp. 1162-1168, 2012.
, “Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating Mycobacterium tuberculosis”, Journal of Biomolecular Structure & Dynamics, vol. 39, no. 3, pp. 889-900, 2021.
, “One pot solvent free synthesis and in vitro antitubercular screening of 3-aracylphthalides against mycobacterium tuberculosis”, Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 3, pp. 711-714, 2013.
, “Novel tetrazoloquinoline-thiazolidinone conjugates as possible antitubercular agents: synthesis and molecular docking”, Medchemcomm, vol. 7, no. 9, pp. 1832-1848, 2016.
, “Novel tetrazoloquinoline-rhodanine conjugates: highly efficient synthesis and biological evaluation”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2278-2283, 2016.
, “Novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents”, Journal of Microbiological Methods, vol. 84, no. 2, pp. 202-207, 2011.
, “Novel red fluorescence protein based microplate assay for drug screening against dormant mycobacterium tuberculosis by using paraffin”, Tuberculosis, vol. 110, pp. 15-19, 2018.
, “Novel gene similar to nitrite reductase (NO forming) plays potentially important role in the latency of tuberculosis”, Scientific Reports, vol. 11, no. 1, p. 19813, 2021.
, “Novel benzylidenehydrazide-1,2,3-triazole conjugates as antitubercular agents: synthesis and molecular docking”, Mini Reviews in Medicinal Chemistry, vol. 18, 2018.
, “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
, “Nitrite reductase NirBD is induced and plays an important role during in vitro dormancy of mycobacterium tuberculosis”, Journal of Bacteriology, vol. 195, no. 20, pp. 4592-4599, 2013.
, “Nitrate reduction pathways in mycobacteria and their implications during latency”, Microbiology-SGM, vol. 158, pp. 301-307, 2012.
, “New pimarane diterpenes and other antimycobacterial metabolites from anisochilus verticillatus”, Natural Product Research, vol. 30, no. 6, pp. 675-681, 2016.
, “New dinor-cis-labdane diterpene and flavonoids with antimycobacterium activity from colebrookea oppositifolia”, Planta Medica Letters, vol. 3, no. 1, pp. e20-e24, 2016.
, “New butenolide cinnamate and other biological active chemical constituents from Polygonum glabrum”, Natural Product Research, vol. 29, no. 22, pp. 2080-2086, 2015.
, “New bithiazolyl hydrazones: novel synthesis, characterization and antitubercular evaluation”, Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 2, pp. 288–294, 2017.
, “Naturally occurring anti-TB agents: isolation, chemical transformations and in vitro antitubercular activities of secondary metabolites of rhizomes of alpinia galanga”, Planta Medica International Open, vol. 3, no. 3, pp. e55-e59, 2016.
, “Multifunctional silica nanoparticles for pancreatic cancer specific drug delivery and bioimaging”, Journal of Chemistry & Applied Biochemistry, vol. 2, no. 1, 2015.
, “Multifunctional inulin tethered silver-graphene quantum dots nanotheranostic module for pancreatic cancer therapy”, Material Science and Engineering C- Materials for Biological Application, vol. 78, 2017.
, “Multifunctional inulin tethered silver-graphene quantum dots nanotheranostic module for pancreatic cancer therapy”, Material Science and Engineering C- Materials for Biological Application, vol. 78, 2017.
, “Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against mycobacterium tuberculosis”, RSC Advances, vol. 8, no. 19, pp. 10634-10643, 2018.
, “Method to extract intact and pure RNA from mycobacteria”, Analytical Biochemistry, vol. 417, no. 2, pp. 286-288, 2011.
, “Leucas mollissima, a source of bioactive compounds with antimalarial and antimycobacterium activities”, Planta Medica Letter, vol. 2, no. 1, pp. e35-e38, 2015.
, “Isolates of alpinia officinarum hance as COX-2 inhibitors: evidence from anti-inflammatory, antioxidant and molecular docking studies”, International Immunopharmacology, vol. 33, pp. 8-17, 2016.
, “Intrinsic therapeutic and biocatalytic roles of ionic liquid mediated self-assembled platinum-phytase nanospheres”, RSC Advances, vol. 5, no. 77, pp. 62871-62881, 2015.
, “Inhibition of amyloid β1-42 peptide aggregation by newly designed cyclometallated palladium complexes”, International Journal of Biological Macromolecules, vol. 248, p. 125847, 2023.
, “In vitro antitubercular screening and in silico study of germacradienolide from blainvillea latifolia”, Asian Journal of Chemistry, vol. 33, no. 12, pp. 3129-3133, 2021.
, “In vitro and ex vivo antitubercular activity of diarylheptanoids from the rhizomes of alpinia officinarum hance”, Natural Product Research, vol. 30, no. 24, pp. 2825-2830, 2016.
, “In silico studies, synthesis and antitubercular activity of some novel quinoline - azitidinone derivatives”, Current Computer-Aided Drug Design, vol. 17, no. 1, pp. 134-143, 2021.
, “Identification of a respiratory-type nitrate reductase and its role for survival of mycobacterium smegmatis in wayne model”, Microbial Pathogenesis, vol. 41, no. 2-3, pp. 90-95, 2006.
, “Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies”, European Journal of Medicinal Chemistry, vol. 127, 2017.
, “High-throughput screening of RNA polymerase inhibitors using a fluorescent UTP analog”, Journal of Biomolecular Screening, vol. 11, no. 8, pp. 968-976, 2006.
, “Highly efficient one-pot multi-component synthesis of alpha-aminophosphonates and bis-alpha-aminophosphonates catalyzed by heterogeneous reusable silica supported dodecatungstophosphoric acid (DTP/SiO2) at ambient temperature and their antitubercular eval”, RSC Advances, vol. 4, no. 15, pp. 7666-7672, 2014.
, “High content screening assay for identifying inhibitors against active and dormant state intracellular Mycobacterium tuberculosis”, Journal of Microbiological Methods, vol. 164, 2019.
, “GSH Induced controlled release of levofloxacin from a purpose-built prodrug: luminescence response for probing the drug release in escherichia coli and staphylococcus aureus”, Bioconjugate Chemistry, vol. 27, no. 9, pp. 2062-2070, 2016.
, “Graphene quantum dots conjugated albumin nanoparticles for targeted drug delivery and imaging of pancreatic cancer”, Journal of Materials Chemistry B, vol. 2, no. 21, pp. 3190-3195, 2014.
, “Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1704-1708, 2016.
, “Exploring the pharmacological potentials of biosurfactant derived from planococcus maritimus SAMP MCC 3013”, Current Microbiology, vol. 77, no. 3, pp. 452-459, 2020.
, “Evidence of nitrite acting as a stable and robust inducer of non-cultivability in Mycobacterium tuberculosis with physiological relevance”, Scientific Reports, vol. 9, p. 9261, 2019.
, “[Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity”, Research on Chemical Intermediates, vol. 42, no. 8, pp. 6607-6626, 2016.
, “DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium(ii) complexes”, Dalton Transactions, vol. 51, no. 42, pp. 16371-16382, 2022.
, “Development of a simple high-throughput screening protocol based on biosynthetic activity of Mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors”, Journal of Biomolecular Screening, vol. 11, no. 8, pp. 1035-1042, 2006.
, “Development of a simple assay protocol for high-throughput screening of mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors”, Journal of Biomolecular Screening, vol. 10, no. 7, pp. 725-729, 2005.